Evidence map›Paper›PMID 22391532›Full record

ArticleAntimicrobial agents and chemotherapy2012

Recurrent episodes of candidemia due to Candida glabrata with a mutation in hot spot 1 of the FKS2 gene developed after prolonged therapy with caspofungin.

María Teresa Durán-Valle, Sara Gago, Alicia Gómez-López, Manuel Cuenca-Estrella, Leticia Jiménez Díez-Canseco, José Luis Gómez-Garcés, Oscar Zaragoza

Abstract readCase Reports
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Journal of fungi (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Inflammatory Cell Recruitment inJournal of clinical medicine · 2019
    Article
  6. Article
  7. Rapid emergence ofMedical mycology case reports · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Assessment of caspofungin susceptibility of Candida glabrata by the Etest®, CLSI, and EUCAST methods, and detection of FKS1 and FKS2 mutations.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2014
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

María Teresa Durán-ValleServicio de Microbiología, Hospital Universitario de Móstoles, Madrid, Spain.
Sara Gago
Alicia Gómez-López
Manuel Cuenca-Estrella
Leticia Jiménez Díez-Canseco
José Luis Gómez-Garcés
Oscar Zaragoza
Centro Nacional de Microbiologia · ESHospital Universitario de Móstoles · ESInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report two episodes of recurrent candidemia caused by echinocandin-resistant Candida glabrata in a 69-year-old patient who underwent repeated abdominal surgery. In the first episode of candidemia, an echinocandin-susceptible Candida glabrata strain was isolated, and the patient was treated with caspofungin. The isolates from the later episodes showed resistance to echinocandins. Analysis of the HS1 region of the FKS2 gene showed the amino acid substitution S663P. Microsatellite analysis demonstrated a strong genetic relationship between the isolates.

Indexed as

AgedAntifungal AgentsCandida glabrataCandidemiaCaspofunginEchinocandinsFungal ProteinsHumansLipopeptidesMaleMutationAntifungal AgentsCaspofunginEchinocandinsFungal ProteinsLipopeptides

Identifiers

PMID22391532
PMCPMC3370789
OpenAlexW2106606124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.